Literature DB >> 22391566

EpCAM regulates cell cycle progression via control of cyclin D1 expression.

A Chaves-Pérez1, B Mack, D Maetzel, H Kremling, C Eggert, U Harréus, O Gires.   

Abstract

The epithelial cell adhesion molecule (EpCAM) is an integral transmembrane protein that is frequently overexpressed in embryonic stem cells, tissue progenitors, carcinomas and cancer-initiating cells. In cancer cells, expression of EpCAM is associated with enhanced proliferation and upregulation of target genes including c-myc. However, the exact molecular mechanisms underlying the observed EpCAM-dependent cell proliferation remained unexplored. Here, we show that EpCAM directly affects cell cycle progression via its capacity to regulate the expression of cyclin D1 at the transcriptional level and depending on the direct interaction partner FHL2 (four-and-a-half LIM domains protein 2). As a result, downstream events such as phosphorylation of the retinoblastoma protein (Rb) and expression of cyclins E and A are similarly affected. In vivo, EpCAM expression strength and pattern are both positively correlated with the proliferation marker Ki67, high expression and nuclear localisation of cyclin D1, and Rb phosphorylation. Thus, EpCAM enhances cell cycle progression via the classical cyclin-regulated pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22391566     DOI: 10.1038/onc.2012.75

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  60 in total

Review 1.  Expression kinetics of hepatic progenitor markers in cellular models of human liver development recapitulating hepatocyte and biliary cell fate commitment.

Authors:  Pooja Chaudhari; Lipeng Tian; Abhijeet Deshmukh; Yoon-Young Jang
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-06

Review 2.  Receptor tyrosine kinases in the nucleus.

Authors:  Graham Carpenter; Hong-Jun Liao
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-10-01       Impact factor: 10.005

3.  A high-content screen for small-molecule regulators of epithelial cell-adhesion molecule (EpCAM) cleavage yields a robust inhibitor.

Authors:  Jana Ylva Tretter; Kenji Schorpp; Elke Luxenburger; Johannes Trambauer; Harald Steiner; Kamyar Hadian; Olivier Gires; Dierk Niessing
Journal:  J Biol Chem       Date:  2018-04-26       Impact factor: 5.157

4.  Anti-EpCAM antibodies for detection of metastatic carcinoma in effusions and peritoneal wash.

Authors:  Fabiana Pirani Carneiro; Maria Imaculada Muniz-Junqueira; Marcos De Vasconcelos Carneiro; Ísis De Araújo Oliveira; Aluízio Carlos Soares; Nathália De Vargas Haar; Gustavo Henrique Soares Takano; Leonora Maciel De Sousa Vianna; Guilherme De Carvalho Caldas; Danillo Leal Marinho Vieira; Lígia Lins Frutuoso; Larissa Matos Rodrigues Brito; Rafael Vieira Martins De Siqueira; Amanda Moreira Parente; Tercia Maria Mendes Lousa De Castro; Isabela Peres; Lianna Martha Soares Mendes; Tatiana Karla Dos Santos Borges; Vânia Moraes Ferreira; Andrea Barretto Motoyama
Journal:  Oncol Lett       Date:  2019-06-12       Impact factor: 2.967

5.  The extracellular domain of epithelial cell adhesion molecule (EpCAM) enhances multipotency of mesenchymal stem cells through EGFR-LIN28-LET7 signaling.

Authors:  I-I Kuan; Chi-Chiu Lee; Chien-Hsu Chen; Jean Lu; Yuan-Sung Kuo; Han-Chung Wu
Journal:  J Biol Chem       Date:  2019-03-29       Impact factor: 5.157

6.  Cleavage and cell adhesion properties of human epithelial cell adhesion molecule (HEPCAM).

Authors:  Thanos Tsaktanis; Heidi Kremling; Miha Pavšič; Ricarda von Stackelberg; Brigitte Mack; Akio Fukumori; Harald Steiner; Franziska Vielmuth; Volker Spindler; Zhe Huang; Jasmine Jakubowski; Nikolas H Stoecklein; Elke Luxenburger; Kirsten Lauber; Brigita Lenarčič; Olivier Gires
Journal:  J Biol Chem       Date:  2015-08-19       Impact factor: 5.157

7.  Functional consequences of EpCam mutation in mice and men.

Authors:  James L Mueller; Matthew D McGeough; Carla A Peña; Mamata Sivagnanam
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-12-12       Impact factor: 4.052

8.  Elevation of Plasminogen Activator Inhibitor-1 promotes differentiation of Cancer Stem-like Cell state by Hepatitis C Virus infection.

Authors:  Da-Eun Nam; Angelina Angelucci; Dahsom Choi; Arnold Leigh; Hae Chang Seong; Young S Hahn
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

9.  EpCAM-Regulated Transcription Exerts Influences on Nanomechanical Properties of Endometrial Cancer Cells That Promote Epithelial-to-Mesenchymal Transition.

Authors:  Ya-Ting Hsu; Pawel Osmulski; Yao Wang; Yi-Wen Huang; Lu Liu; Jianhua Ruan; Victor X Jin; Nameer B Kirma; Maria E Gaczynska; Tim Hui-Ming Huang
Journal:  Cancer Res       Date:  2016-08-28       Impact factor: 12.701

10.  Prediction of survival in resected non-small cell lung cancer using a protein expression-based risk model: implications for personalized chemoprevention and therapy.

Authors:  Kathryn A Gold; Edward S Kim; Diane D Liu; Ping Yuan; Carmen Behrens; Luisa M Solis; Humam Kadara; David C Rice; Ignacio I Wistuba; Stephen G Swisher; Wayne L Hofstetter; J Jack Lee; Waun K Hong
Journal:  Clin Cancer Res       Date:  2013-12-23       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.